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Cancer bladderAbstract Purpose: To evaluate the ability of diffusion-weighted imaging (DWI) in T staging of
urinary bladder cancer and the correlation between the apparent diffusion coefﬁcient (ADC) and
tumor grading.
Patients and methods: This study included 40 patients with bladder mass diagnosed by ultrasonog-
raphy. MR imaging sequences included, T2WI, DWI, ADC and T1 postcontrast MRI were done.
The correlation between magnetic resonance ﬁndings and histopathological results was done.
Results: Of all forty patients, 14 patients (35%) were T1, 18 (45%) patients were T2, and 8 (20%)
patients were T3. The overall accuracy of T2WI, DWI and postcontrast imaging sequences in dif-
ferentiating superﬁcial from invasive tumor was 60%, 85% and 75% respectively. The overall accu-
racy of T2WI, DWI and postcontrast imaging sequences in differentiating organ conﬁned from
non-organ conﬁned tumor was 80%, 90% and 70% respectively. The mean ADC value was
0.95 ± 0.13 · 10–3 mm2/s in low grade tumors and 0.69 ± 0.12 · 10–3 mm2/s in high grade tumors.
Conclusion: DWI has a higher overall accuracy compared to both T2WI and postcontrast T1WI in
T staging of bladder cancer, and also ADC value can predict the tumor grade. So, DWI can be rec-
ommended as promising MRI sequence in urinary bladder T staging and grading.
 2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Urinary bladder cancer is the second most common cancer of
the genitourinary system (1), and bladder cancer in Egypt has
signiﬁcantly changed within the last three decades as transi-
tional cell carcinoma (TCC) becomes themost common type (2).
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cancer staging; however, imaging assessment forms a vital part
of the management protocol (3). Cystoscopy with biopsy is still
the gold standard tool for bladder cancer staging due to its
high sensitivity in detecting lesions and the possibilities of
tumor resections (4), invasiveness, limitation in detection of(A)
(C)
(E)
Fig. 1 56 old male histopathologically conﬁrmed transitional cell carc
lesion disrupting hypointense muscle layer at base of the mass, over s
heterogeneous contrast enhancement with almost indistinct urinary b
restricted diffusion evident by C-shaped high signal intensity with a lo
denoting stage T1 representing accurate staging. ADC value (E) measur
tumor.ﬂat lesions, and lack of the assessment of extra-vesical tumor
invasion represent the main drawbacks (5).
Proper staging and grading of bladder tumor are crucial for
management (6). Under staging subjects patients to subopti-
mal treatment while over staging subjects patients to unwar-
ranted treatment-related morbidity (7).(D)
(B)
inoma T1, G1 tumor. T2WI (A and B) shows small fungating mass
taged as stage T2a. Post contrast T1 WI (C) the mass is showing
ladder wall, over staged as stage T2. DWI (D) the mass showed
w SI stalk connecting to left bladder wall (b= 500 and b= 1000)
ed within the ROI was 0.98 · 103 mm2/s denoting low grade (G1)
The role of diffusion-weighted magnetic resonance imaging 743Magnetic resonance imaging is the modality of choice in
imaging bladder tumor and its accuracy ranges from 73% to
96%, and these values are 10–33% higher than CT staging
of bladder cancer (3,8).
Diffusion weighted imaging (DWI) reveals micro-molecular
diffusion. This can delineate pathologic lesions with high tissue
contrast against generally suppressed background signal (9).
DWI can provide useful information for T staging of bladder
cancer (10).
Apparent diffusion coefﬁcient (ADC) representing the
degree of water molecular diffusion and the degree of restric-
tion to water diffusion in biological tissues is inversely corre-
lated to the tissue cellularity and the integrity of the cell
membranes (11).
Several authors have already reported decreased
ADC values among various malignant lesions due to dense cel-
lularity and large cellular size (11,12).(A)
(C)
Fig. 2 68 old male histopathologically conﬁrmed transitional cell ca
showed 4 fungating soft tissue mass lesions seen involving the dome, lef
display intermediate signal intensity with irregular inner margin of hyp
intact hypointense line accurately staged as T1. Axial T1 post contras
intact muscle layer accurately staged as stage T1. DWI (C): The fou
restricted diffusion. The domal lesions show intrinsic submucosal stalk
walls are seen clearly identiﬁed with no disruption accurately staged as
s over graded as high grade tumor. The mean ADC values of the other
1.1 · 10-3 mm2/s. accurately graded as low grade tumor.ADC quantitatively differentiates benign from malignant
lesions (9). In addition, the ADC can predict the histologic
grade of bladder cancer (10).
The aim of this work was to evaluate the ability of
diffusion-weighted imaging T-stage of bladder cancer and to
ﬁnd correlation between the apparent diffusion coefﬁcient
(ADC) and histologic grade.
2. Patients and methods
In this prospective study, 40 patients (28 males and 12 females)
presented with bladder mass were diagnosed using ultrasound,
in the period between October 2012 and April 2014. Their ages
ranged from 52 to 70 years. A full history was obtained from
all patients with special attention to hematuria, pain, passage
of blood clots or necroturia, dysuria, frequency and urgency.
A thorough clinical examination with special attention to(D)
(B)
rcinoma staged T1, low grade (G1). Axial T2-weighted image (A)
t lateral wall and base of the urinary bladder, the large domal mass
ointense line over staged as stage T2a. Other three masses showing
t image (B) showed homogenous enhanced soft tissue masses with
r bladder mass lesions are clearly detected, showing evidence of
while the others show submucosal thickening. The urinary bladder
stage T1. ADC values (D) of the domal mass was 0.71 · 103 mm2/
bladder lesions measure 1.02 · 103 mm2/s, 0.99 · 103 mm2/s and
(A)
(C) (D)
(B)
Fig. 3 64 old male histopathologically conﬁrmed transitional cell carcinoma staged T2b, high grade (G3). Sagittal T2-weighted image
(A) showed poorly deﬁned endophytic fungating large soft tissue mass lesion in the dome and anterior wall of the bladder and high signal
intensity blood clots seen in the lumen. Mass extending into perivesical fat with an irregular contour. Over staged as stage T3b. Axial T1
post contrast enhanced image (B) shows heterogeneous contrast enhancement of the mass with evidence of focal invasion into the
perivesical fat planes over staged as stage T3. DWI (C) (b= 1000) showed evidence of restricted diffusion with a smooth bulging
accurately staged as stage T2. ADC value (D) was 0.68 · 103 mm2/s denoting high grade tumor (accurate grading).
744 H.M. Abdel-Rahman et al.digital rectal and bimanual examination and a full laboratory
investigation were done for all cases.
Our patients were referred to radio-diagnosis department
from Urology outpatient clinic, after obtaining institutional
review board approval from our hospital and receiving
informed consent from the patients before the study. The
patients exclusion criteria were patients with impaired renal
function (serum creatinine >2 mg/dl), claustrophobia and
metallic implants (see Figs. 1–3).
3. Imaging assessment
Thirtyminutes before theMRI study, all patients were asked for
drinkingwater and presented by full bladder. In 5 patientswith a
urethral catheter, it was closed one hour before examination.
MR imaging was performed with a 1.5-T Philips Achieva
system class II by using a pelvic phased-array coil with the
patient in supine position. MR imaging examination included
T2WI, DWI and T1WI postcontrast.
After localizer images, T2-weighted spin-echo MR images
were obtained from the aortic bifurcation to the symphysispubis with the following parameters: repetition time msec/echo
time msec, 4400/120, section thickness, 4 mm; intersection gap,
0.4 mm; ﬁeld of view, 23 cm; matrix, 256 · 190. T2-weighted
images were done in the axial and sagittal planes.
Diffusion-weighted images were obtained by using single
shot spin-echo echo-planar imaging with a pair of rectangular
gradient pulses along three orthogonal axes. The imaging
parameters were as follows: TR/TE = 2800/74; ﬁeld of view
25 cm, section thickness, 3 mm; intersection gap, 1 mm.
Images were zero-ﬁlled to a 256 · 256 matrix. The orientation
and location of these images were prescribed identically to the
axial T2-weighted images. The b values were 0, 500 and
1000 s/mm. To gain better signal-to-noise ratios, a larger ﬁeld
of view was used for DW imaging than for T2-weighted imag-
ing, and a thicker section was used for T2-weighted and DW
imaging than for T1-weighted fast ﬁeld echo imaging. DW
images were obtained in the axial and sagittal planes.
ADC maps were formed automatically by the device, circu-
lar regions of interest (ROIs) were set to be at least 20 mm2 in
order to minimize the inﬂuence of potential motion artifacts
ranging from 10 to 40 mm2 according to the size of the mass,
Table 1 T2WI, DWI and postcontrast T1WI criteria of T-staging.
T2WI (13) DWI (10) Postcontrast T1WI (14)
6T1 Intact low SI muscle-layer at the base
of the tumor
A thin, ﬂat, high SI tumor or a high SI tumor with a
low SI submucosal stalk or a thickened submucosa
Intact submucosal linear enhancement
(SLE) adjacent to the tumor
T2 A lesion with focally disrupted
muscle-layer without perivesical
inﬁltration
A high SI tumor without a submucosal stalk and
with a smooth tumor margin
SLE was disrupted by a tumor but there
was no inﬁltration into the perivesical fat
T3 A lesion extending into the
perivesical fat
Extension into the perivesical fat with an irregular
margin
Tumors invading the perivesical fat
T4 A lesion extending into the adjacent
organs
Extension into adjacent organs Tumor extended to the adjacent organs
The role of diffusion-weighted magnetic resonance imaging 745and it was placed in the center of the lesion in cases of large
masses. ADC value was obtained with b values 500 and
1000 s/mm2. The ADC values are expressed in square millime-
ters per second.
T1-weighted fast ﬁeld-echo images with and without fat
suppression technique; TR/TE = 500/20; matrix, 224 · 214;
section thickness, 3 mm; gapless; ﬁeld of view, 35 cm; were
obtained before and after administration of 0.2 mL
per/Kilogram of body weight gadopentetate dimeglumineTable 2 T2WI staging results on a stage-by-stage basis
compared with histopathological staging.
T2 weighted imaging stage Histopathology stage
6T1 T2 T3 T4 Total
6T1 4 6 0 0 10
T2 8 10 4 0 22
T3 2 2 4 0 8
T4 0 0 0 0 0
Total 14 18 8 0 40
Table 3 DWI staging results on a stage-by-stage basis
compared with histopathological staging.
DW imaging stage Histopathology stage
6T1 T2 T3 T4 Total
6T1 12 4 0 0 16
T2 2 14 4 0 20
T3 0 0 4 0 4
T4 0 0 0 0 0
Total 14 18 8 0 40
Table 4 Postcontrast T1WI staging results on a stage-by-
stage basis compared with histopathological staging.
Postcontrast T1WI stage Histopathology stage
6T1 T2 T3 T4 Total
6T1 6 2 0 0 8
T2 8 10 6 0 24
T3 0 6 2 0 8
T4 0 0 0 0 0
Total 14 18 8 0 40(postcontrast study was done 20 s after injection of contrast
medium).
The patients were referred again to Urology department.
Diagnostic cystoscopy and transurethral resection of bladder
tumor (TURBT), examination under anesthesia before and
after TURBT were done for all patients and radical cystec-
tomy was done for 28 patients.
4. Image interpretation
Imaging sequence sets (T2-weighted images, DW images and
T1 postcontrast-enhanced images) were randomly reviewed
by two radiologists (H M and I M with 10 years of experience)
who were blinded to cystoscopic and histopathological results.
T-staging depends on criteria shown in Table 1.
Correlation between MR ﬁndings and histopathological
results (after TURBT or radical cystectomy) was done.
Data were checked, entered and analyzed using SPSS
version 13 for data processing and statistics. Mann–Whitney
U-test was used to compare the mean ADC value of patients
with low grade tumor (G1) and patients with high grade tumor
(G2 or G3). Receiver operating characteristic (ROC) curve was
used to select an optimal cutoff value of ADC. For all statisti-
cal tests were done, the threshold of signiﬁcance was ﬁxed at
5% level (P-value).Table 5 Sensitivity, speciﬁcity and accuracy for differentiat-
ing superﬁcial tumors (6T1) from invasive tumors (>T1).
Image Sensitivity Speciﬁcity Accuracy
No. % No. % No. %
T2WI 20/26 76.92 4/14 28.57 24/40 60
DWI 22/26 84.62 12/14 85.71 34/40 85
Postcontrast T1WI 24/26 92.31 6/14 42.86 30/40 75
Table 6 Sensitivity, speciﬁcity and accuracy for differentiat-
ing organ conﬁned tumors (6T2) from non-organ conﬁned
tumors (>T2).
Image Sensitivity Speciﬁcity Accuracy
No. % No. % No. %
T2WI 4/8 50 28/32 87.5 32/40 80
DWI 4/8 50 32/32 100 36/40 90
Postcontrast T1WI 2/8 25 26/32 81.25 28/40 70
Table 7 Comparison between ADC values and histopatho-
logical grades.
Low grade
(G1) tumors
High grade (G2
and G3) tumors
P
value
Mean · 103 mm2/
s ± SD
0.95 ± 0.13 0.69 ± 0.12 0.0001*
* <0.05 signiﬁcant.
Table 8 Cutoff value between low grade (G1) and high grade
(G2 and G3) tumor by b value 1000 s/mm2.
Cutoﬀ value
(b= 1000
s/mm2)
Sensitivity Speciﬁcity P
value
Low grade
versus high
grade
0.82 100.0 100.0 0.001*
* <0.05 signiﬁcant.
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This study included 40 patients with bladder mass. They were
28 males (70%) and 12 females (30%). Their ages ranged from
52 to 70 years. The most common clinical symptom was pain-
less hematuria presented in 36 patients (90%).
One case had diffuse wall thickening, and DWI predicts the
site of tumor, while T2WI and T1 postcontrast cannot predict
the site of tumor.
Regarding to histopathological results, transitional cell car-
cinoma was found in 34 (85%) patients, squamous cell carci-
noma was found in 4 patients (10%) and adenocarcinoma was
found in 2 patients (5%). Concerning MR staging, 14 patients
(35%) were staged as T1, 18 patients (45%) staged as T2, 8
patients (20%) staged as T3 andwe have no patient staged as T4.
Tables 2–4 showed that T2WI staging was correct in 18
patients (45%), under staging occurred in 10 patients (25%)
and over staging occurred in 12 patients (30%). DWI staging
was correct in 30 patients (75%), under staging occurred in 8
patients (20%) and over staging occurred in 2 patients (5%).
Postcontrast enhanced T1WI staging was correct in 18 patients
(45%), under staging occurred in 8 patients (20%) and over
staging occurred in 14 patients (35%).
Accuracy of T2WI for proper tumor staging was 28.6%,
55.6% and 50% for stages T1, T2 and T3 respectively.
Accuracy of DWI for proper tumor staging was 85.7%,
77.8% and 50% for stages T1, T2 and T3 respectively.
Accuracy of postcontrast enhanced T1WI for proper tumor
staging was 42.9%, 55.6% and 25% for stages T1, T2 and
T3 respectively.
Table 5 showed sensitivity, speciﬁcity and accuracy for dif-
ferentiating superﬁcial tumors (6T1) from invasive tumors
(>T1).
Table 6 showed that the speciﬁcity and accuracy of DWI
are higher than that of T2WI and postcontrast imaging
sequences in differentiating organ conﬁned from non-organ
conﬁned tumor.
Table 7 showed that mean ADC value is high in low grade
tumors and low in high grade tumors.Table 8 showed cutoff value between low grade (G1) and
high grade (G2, and G3) tumors by b value 1000 s/mm2.
6. Discussion
As known, MRI has multiple advantages such as, no ionizing
radiation, high spatial resolution and high soft tissue contrast
(15), DWI was ﬁrst applied in the brain and became the ‘gold
standard’ imaging for the diagnosis of acute stroke (16). After
technical advances such as fast sequences, DWI has been
applied in the abdomen and pelvis including urinary tract
tumors (10,17).
DWI has a high level of diagnostic performance in detect-
ing bladder cancer and is comparable to T2WI but with better
inter-observer agreement, this may be due to the clear contrast
visible in DWI; signals of bladder cancer are very bright while
images of surrounding tissues appear muted (18).
Recently, quantiﬁcation of tissue by ADC has been more
commonly used to assess the pathophysiological characteris-
tics of bladder cancer. ADC was shown to be able to differen-
tiate malignant tissues from normal bladder wall or benign
tissues (19). In tumor grading, ADC values were reported to
be signiﬁcantly lower in high grade than in low grade (18).
The feasibility of using DWI in the detection of a urinary
bladder carcinoma was reported by Matsuki et al. (20), and
in their study the sensitivity in detecting the carcinomas was
100%. The same ﬁndings were also reported by El-Assmy
et al. (8), and in their study the sensitivity of DWI was
100% in terms of correctly detecting the carcinomas.
However the previous studies did not compare the sensitiv-
ity of DWI with T2-WI. In our study the sensitivity of DWI
was 100% regarding the carcinomas; however, the sensitivity
of T2WI and postcontrast T1WI was 97.5%. In one patient,
T2-WI and postcontrast T1WI only showed diffuse bladder
wall thickening without any mass lesion; however, DWI
revealed malignant mass lesion inside the diffuse wall thicken-
ing which helps urologist to take a biopsy at cystoscopy from
suspected lesion which conﬁrmed histopathologically to be
squamous cell carcinoma.
In the current study, postcontrast T1WI has sensitivity and
speciﬁcity of 25% and 81.25% respectively for distinguishing
T2 stage or below (organ conﬁned tumor) from T3 stage or
higher (non-organ conﬁned tumor). Our results are in agree-
ment with the results of Tekes et al. (21) concerning speciﬁcity;
however, our results showed lower sensitivity, as they reported
sensitivity and speciﬁcity of 86% and 84% respectively for dis-
tinguishing T2 stage or below from T3 stage or higher.
In this study the DWI staging accuracy in differentiating
superﬁcial from invasive tumor and organ conﬁned from
non-organ conﬁned tumors was 85% and 90% respectively
and this is higher than the results of El-Assmy’s et al. (22),
who reported that DWI staging accuracy was 63.6% and
69.6% in differentiating superﬁcial from invasive tumors and
organ-conﬁned from non-organ-conﬁned tumors, respectively.
A retrospective study published by Watanabe et al. (23)
compared DWI with T2 weighted and gadolinium enhanced
techniques for determining tumor invasion into the bladder
wall, and comparing the ﬁndings with histopathology.
Tumor T-stage was correct in 68% of patients with DWI,
58% with contrast enhanced and 53% with T2 weighted imag-
ing. Our study was in line with their results as tumor T stage
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weighted imaging and 45% with contrast enhanced T1WI.
El-Assmy et al. (22) have reported the accuracy of DWI for
individual tumor stages. They found that the accuracy of DWI
for correctly identifying tumor stage was 63.6%, 75.7% and
93.7% for stages T1, T2 and T3 respectively. Our study was
comparable to these results as accuracy of DWI for correctly
identifying tumor stage was 85.7%, 77.8%, 50% respectively.
The low percent in T3 in our study could be explained by small
number of cases.
In our study the mean ADC values were
(0.95) · 103 mm2/s, (0.69) · 103 mm2/s for low grade tumor
(G1) and high grade tumor (G2 or G3), respectively. This is
in agreement with Takeuchi et al. and Kobayashi et al.
(10,18). Both studies demonstrate that ADC values in the
tumors of higher grade were found to be signiﬁcantly lower
than those in tumors of lower grade.
7. Conclusions
DWI has a higher overall accuracy compared to both T2WI
and postcontrast T1WI in T staging of bladder cancer, and
also ADC map can predict the tumor grade. So DWI can be
recommended as promising MRI sequence in urinary bladder
T staging and grading.
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